These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 6182756)

  • 1. [Clinical, biochemical and psychopharmacologic correlates in patients with depressive symptomatology].
    Martín JL; Spatz H; Abdala NE; Basombrio J
    Acta Psiquiatr Psicol Am Lat; 1980 Mar; 26(1):13-25. PubMed ID: 6182756
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urinary MHPG levels and tricyclic antidepressant drug selection. A preliminary communication on improved drug selection in clinical practice.
    Cobbin DM; Requin-Blow B; Williams LR; Williams WO
    Arch Gen Psychiatry; 1979 Sep; 36(10):1111-5. PubMed ID: 475544
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urinary 3-methoxy-4-hydroxyphenylglycol (MHPG) excretion in depression.
    Steiner M; Radwan M; Elizur A; Blum I; Atsmon A; Davidson S
    Jpn J Exp Med; 1979 Apr; 49(2):95-9. PubMed ID: 480680
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Variations in the urinary level of MHPG in depressive syndromes].
    Loeb C; Roccatagliatà G; Besio G
    Schweiz Arch Neurol Neurochir Psychiatr; 1979; 125(2):337-48. PubMed ID: 555549
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Plasma levels of MHPG, HVA and total 5-HIAA in depression. Preliminary study].
    Raucoules D; Levy C; Azorin JM; Bruno M; Valli M
    Encephale; 1992; 18(6):611-6. PubMed ID: 1285270
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Determination of 3-methoxy-4-hydroxyphenyethylene-glycol and its urinary conjugates. Value in the diagnosis and therapeutic follow-up of depression].
    Tapie M; Garnier JP; Tremine T; Bousquet B; Manet L; Dreux C; Lauzel JP
    Pathol Biol (Paris); 1988 Mar; 36(3):217-23. PubMed ID: 2452402
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urinary amine metabolites in depression: a combined biochemical and general practice study: II. Biochemical aspects.
    Ridges AP; Bishop FM; Goldberg IJ
    J Int Med Res; 1980; 8 Suppl 3():37-44. PubMed ID: 6162689
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Respective position of antidepressants in therapeutics (author's transl)].
    Moussaoui D
    Encephale; 1979; 5(5 Suppl):701-8. PubMed ID: 95010
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 3-Methoxy-4-hydroxyphenylglycol and primary depression: clinical and pharmacological considerations.
    Sacchetti E; Allaria E; Negri F; Biondi PA; Smeraldi E; Cazzullo CL
    Biol Psychiatry; 1979 Jun; 14(3):473-84. PubMed ID: 476232
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Do low levels of MHPG in depressive spectrum patients normalize after successful treatment?
    Garvey MJ; Tuason VB
    Neuropsychobiology; 1996; 34(4):188-91. PubMed ID: 9121619
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Review and updating of the diagnostic sensibility of the dexamethasone suppression test and urinary determination of phenylethylamine and 3-methoxy-4-hydroxyphenylethylglycol in the diagnosis of endogenous depression].
    Ciprian-Ollivier J; Boullosa O; Bakmas MC
    Acta Psiquiatr Psicol Am Lat; 1987 Jun; 33(2):142-8. PubMed ID: 3321917
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Platelet serotonin in endogenous depressive patients and normal controls].
    Spatz H; Spatz N
    Acta Psiquiatr Psicol Am Lat; 1995 Sep; 41(3):230-6. PubMed ID: 8728799
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biological markers in depression. Monoamine metabolites in urine of depressed patients and normal subjects.
    Vandel S; Vandel B; Bonin B; Camejo Z; Sandoz M; Allers G; Volmat R
    Pharmacopsychiatry; 1985 Nov; 18(6):347-50. PubMed ID: 2418451
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biochemistry and treatment strategies for depression.
    Garvey MJ
    J Fam Pract; 1980 Aug; 11(2):215-9. PubMed ID: 6106040
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of depression with tricyclic drugs--pharmacokinetic and pharmacodynamic aspects.
    Asberg M
    Pharmakopsychiatr Neuropsychopharmakol; 1976 Jan; 9(1):18-26. PubMed ID: 10583
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Urinary MHPG in patients with endogenous depression and the effectiveness of antidepressive drugs].
    Puzyński S; Bidziński A; Rode A; Mrozek S; Załuska M
    Psychiatr Pol; 1984; 18(2):115-22. PubMed ID: 6514870
    [No Abstract]   [Full Text] [Related]  

  • 17. Subtypes of depression--diagnosis and medical management.
    Bielski RJ; Friedel RO
    West J Med; 1977 May; 126(5):347-52. PubMed ID: 17227
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urinary MHPG in depression.
    Cobbin D
    Med J Aust; 1980 Apr; 1(8):389. PubMed ID: 7393085
    [No Abstract]   [Full Text] [Related]  

  • 19. Urinary MHPG excretion and treatment with desipramine or amitriptyline: prediction of response, effect of treatment, and methodological hazards.
    Veith RC; Bielski RJ; Bloom V; Fawcett JA; Narasimhachari N; Friedel RO
    J Clin Psychopharmacol; 1983 Feb; 3(1):18-27. PubMed ID: 6833519
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urinary MHPG in depression: a cautionary note.
    Johnson G
    Med J Aust; 1980 Jan; 1(1):37. PubMed ID: 7360075
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.